Open mobile menu
Model.SiteSettings!.GetInTouchLink!.Name Contact Us
Jroberts Jruaux Dpingstone 03 B012378 CROPPED
Insights

News

Stay up to date with news about Secerna and intellectual property topics.

VENCLEXTA®

A to Z: Drugs in Highlight: V is for VENCLEXTA®

News A to Z Feature 30/04/2025

Our A to Z series highlights VENCLEXTA® (venetoclax) from AbbVie, a medication used to treat both chronic lymphocytic leukaemia (CLL) and acute myeloid leukaemia (AML). This article explores its mechanism of action, clinical applications, and the patent protection surrounding this important drug.

Read more
Istock 841265342
Industry news, News 10/02/2023

EPO Added Matter “Not a Commacal Matter”

Brain With Cogs Jan 2022
Industry news 10/02/2023

An Update Regarding the DABUS Debate

Miriam Payne January 2023
Industry news, News 10/02/2023

She did it! Secerna-sponsored physics graduate completes solo Atlantic row with new race record

NCRABTREE - Secerna Headshots September 2024 127
Team news, Careers 22/12/2022

Niamh Crabtree in profile

Untitled Design 2023 02 10T100130.018
News, Team news 15/12/2022

Intrepid explorer sets off to “Seas the Day”

Secerna Christmas Mailer 2022 800X1160px (1)
Team news 15/12/2022

Festive Greetings from all at Secerna

Surgeon
European, Industry news 01/12/2022

New Developments in MedTech Patenting at the European Patent Office

Dermot Roche Press 800X800px Colour Temp Pic
European, Events, Team news 23/11/2022

Secerna to attend Knowledge Transfer Ireland Impact Awards

European Patent Office Building
European, Industry news 08/11/2022

How To Make Life Easier At The EPO – Exclusion of Diagnostic Methods

17 18 19 20 21 22 23 24 25 26 27